Cramer Welcomes Veteran Pharmaceutical Executive to Advisory Board.

Syndax Pharmaceuticals President and CEO Dr. Joanna Horobin Brings Global Perspective to Cramer's Rapidly Growing Healthcare Practice

NORWOOD, Mass. -- Cramer, a digital marketing and event solutions agency, today announced that Dr. Joanna Horobin, president and CEO, Syndax Pharmaceuticals, has joined the company's advisory board. Cramer's advisory board meets quarterly with Cramer CEO Tom Martin and his executive team to lend their insight and expertise to the company's business strategies and long-term planning efforts.

"I'm pleased to welcome Joanna to our advisory board, as her experience and insight in the pharmaceutical industry both here and abroad will be a tremendous asset to our emerging Healthcare Practice," said Tom Martin, CEO, Cramer. "The addition of Joanna to the advisory board is a reflection of Cramer's efforts to maintain both a long-term vision for the company and the industry at-large, while continuing to meet and exceed the expectations of our clients today. It's a very exciting time for all of us here at Cramer as we continue to build our national reputation as an integrated marketing and events solutions agency with a deep and diverse clientele."

Dr. Horobin has more than 20 years of pharmaceutical drug development experience in multiple therapeutic areas, with a focus on oncology and a particular interest in the development of combination strategies. Her management experience includes executive positions in clinical development, marketing and general operations with both public and private companies in the United Kingdom, France and the United States. Dr. Horobin is currently the Director of Nascent Pharmaceuticals, a member and former President of the Boston Chapter of the Healthcare Businesswoman's Association (HBA) and a Director of the acclaimed youth chorus, Boston City Singers. She was formerly Dr. Vice President, Oncology at Rhone-Poulenc Rorer (now Sanofi Aventis) and Chief Operating Officer at CombinatoRx Inc. Dr. Horobin qualified in medicine from the Victoria University of Manchester, England and additionally gained Membership of the Royal College of General Practitioners in the UK, as well holding the Diploma of Pharmaceutical Medicine from the Royal College of Physicians in the UK.

"I am eager to start working with each of the members of the advisory board as well as with Tom Martin and the Cramer executive team, each of whom offer a distinctive mixture of experience and acumen from a variety of backgrounds," said Dr. Joanna Horobin. "I believe that my personal experience as both a physician and an executive in the pharmaceutical industry, here in the United States and abroad, will enable me to provide Cramer with a well-informed point of view on how the company can effectively position itself ahead of industry trends in product development, marketing and sales. I look forward to working closely with the board to help Cramer, especially their new Healthcare Practice, evolve and grow as a leader in the creation and execution of innovative digital marketing and event programs."

Dr. Horobin joins a board that includes luminaries from a variety of industries, including:

* Kirk Arnold: Arnold is President and CEO of Keane Inc., a billion dollar consulting and outsourcing business based in Boston, MA. Previously she served as Executive Vice President of Product, Consulting and Marketing for Fidelity Human Resources Company, a business unit of Fidelity Employer Services Company.

* Terry Carlton: Carlton is Executive Vice President at Hill Holliday. He is also the Chairman of the Board for Source MDx and Chairman of the Board of Trustees at Bentley College and Newton Country Day School of the Sacred Heart.

* Ron Dion: Dion is the Chief Operations and Financial Officer of Bentley Kinetics, a leader in kinetic motion analysis. He was formally the Executive Vice President & CFO of Boston Financial Data Services, Inc., a mutual fund transfer agent company.

* James Coppersmith: Coppersmith is Chairman on the Board of Trustees at Emerson College. He is also on the Board of Directors of BJ's Wholesale Club and is a Director and Vice Chairman of the Board of Directors of Rasky Baerlein Group, a public relations firm. He was formerly President and General Manager of WCVB-TV, New England's Channel 5.

* Shawn Martin: Martin is one of the founders of Convexity Capital, a Boston-based institutional investment management firm founded in 2005. Previously he was an executive at Harvard Management Co., which manages the investment of about half of the Harvard University's endowment.

* Joel Whitman: Whitman founded the Whitman Consulting Group in 2002, which provides a targeted set of consulting and advisory services designed to address the specific needs of large to mid-sized enterprise, small business and not-for profit organizations.

About Cramer

Cramer is a digital marketing and event solutions agency that fuses creativity and technology to design and execute experiences that move audiences. For more than 25 years, the agency has helped the world's leading and emerging brands win and retain loyal customers, launch products and inspire sales teams. Reaching audiences online, offline, through emerging media, and face-to-face, Cramer creates personalized, integrated marketing programs and events that maximize marketing impact - and their clients' dollars. Cramer clients include Boston Scientific, Business Objects, Gillette, JP Morgan, EMD Serono and PricewaterhouseCoopers. Cramer is a privately-held company. For more information please go to www.crameronline.com or visit their blog at www.awidernet.com.